JoomFish-Language Selection

  • Français (Fr)
  • English (United Kingdom)
  • 简体中文
 
 
 
 
Find us on : linkedin_logo  viadeo_logo

2010 Themes

The emphasis of the 2010 Universal Biotech Innovation Grant will be placed on therapeutic innovation.

Applications must be entered under one of the two following thematic areas:

  • Innovative therapies

  • Diagnostic products

Eligibility criteria

The innovations submitted must follow the following conditions:

  • The innovation must be entered under one of the two requested thematic areas
  • The innovation must be subject to a patent or any kind of intellectual property in the process of registration
  • The innovation must not be subject to any form of commercialisation at the time the dossier is submitted

The participants must be:

  • A French or European Young Innovative Company
  • A French or European research team member
  • Individual

The letter of intent must be complete, presented within the allotted timeframes and in the formats requested.

Evaluation criteria

The innovations will be evaluated according to the following criteria.

  • Scientific quality of the innovation
  • Project progress stage
  • Intellectual and industrial property
  • Medical need and positionning
  • Quality of resources
  • Chance of success

Timetable

  • February 2010: opening of application procedures : submission forms available on the website
  • 20 May 2010: closing date for application
  • June 2010: submission of full application forms
  • July 2010: Jury meeting and provisionnal selection announcement
  • August 2010: last jury meeting / oral presentations and final discussion
  • 5 october 2010: Universal Biotech Innovation Grant award ceremony during the Innovation Days, A Pharma & Biotech Event


Download the review "2010 Universal Biotech Innovation Grant"



Partenaires sponsors Sanofi Aventis

Merck & Co
Groupe LFB
Santeos
Partenaires Commission Européenne
Agence Nationale de la recherche
HAS
Inserm
Ministère de l'enseignement supérieur et de la recherche
Medicen Paris région
Angels santé
Actelion pharmaceuticals
Biopharmaceutiques
Cerenis therapeutics
CISS
Fovea pharmaceuticals
IMS Health
Janssen Cilag
Nixon Peabody
Paris Biotech Santé
Pharmaceutiques
Px therapeutics
Biocitech
Actulabo
Actulabo